AbbVie Inc (ABBV)

Debt-to-equity ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	10,360,000	12,094,000	12,866,000	13,274,000	17,254,000	15,994,000	14,653,000	16,283,000	15,408,000	13,550,000	12,569,000	13,710,000	13,076,000	15,270,000	14,708,000	-7,415,000	-8,172,000	-8,226,000	-8,566,000	-7,826,000
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $10,360,000K
= 0.00

The debt-to-equity ratio for Abbvie Inc has been fluctuating over the past eight quarters, ranging from 3.67 to 5.73. Generally, a higher debt-to-equity ratio indicates that a company has been using more debt to finance its operations compared to equity.

In this case, the ratio has been on an increasing trend from Q2 2022 to Q4 2023, indicating a rising level of debt relative to equity during this period. This may suggest that Abbvie Inc has been taking on more debt to fund its business activities, which could potentially increase financial risk and interest payment obligations.

It's crucial for investors and stakeholders to closely monitor this ratio, as a continuously high debt-to-equity ratio could signal financial instability and impact the company's ability to meet its debt obligations in the long run. Further analysis and consideration of other financial metrics are recommended to fully evaluate Abbvie Inc's financial health and sustainability.